000 -LEADER |
fixed length control field |
04165nam a22004335i 4500 |
001 - CONTROL NUMBER |
control field |
978-1-4020-0570-1 |
003 - CONTROL NUMBER IDENTIFIER |
control field |
DE-He213 |
005 - DATE AND TIME OF LATEST TRANSACTION |
control field |
20161121231030.0 |
007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION |
fixed length control field |
cr nn 008mamaa |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
fixed length control field |
100301s2006 ne | s |||| 0|eng d |
020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
International Standard Book Number |
9781402005701 |
-- |
978-1-4020-0570-1 |
024 7# - OTHER STANDARD IDENTIFIER |
Standard number or code |
10.1007/1-4020-0570-9 |
Source of number or code |
doi |
050 #4 - LIBRARY OF CONGRESS CALL NUMBER |
Classification number |
QA276-280 |
072 #7 - SUBJECT CATEGORY CODE |
Subject category code |
PBT |
Source |
bicssc |
072 #7 - SUBJECT CATEGORY CODE |
Subject category code |
MBNS |
Source |
bicssc |
072 #7 - SUBJECT CATEGORY CODE |
Subject category code |
MED090000 |
Source |
bisacsh |
082 04 - DEWEY DECIMAL CLASSIFICATION NUMBER |
Classification number |
519.5 |
Edition number |
23 |
100 1# - MAIN ENTRY--PERSONAL NAME |
Personal name |
Cleophas, Ton J. |
Relator term |
author. |
245 10 - TITLE STATEMENT |
Title |
Statistics Applied to Clinical Trials |
Medium |
[electronic resource] / |
Statement of responsibility, etc. |
by Ton J Cleophas, Aeilko H Zwinderman, Toine F Cleophas. |
264 #1 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE |
Place of production, publication, distribution, manufacture |
Dordrecht : |
Name of producer, publisher, distributor, manufacturer |
Springer Netherlands, |
Date of production, publication, distribution, manufacture, or copyright notice |
2006. |
300 ## - PHYSICAL DESCRIPTION |
Extent |
XIII, 210 p. |
Other physical details |
online resource. |
336 ## - CONTENT TYPE |
Content type term |
text |
Content type code |
txt |
Source |
rdacontent |
337 ## - MEDIA TYPE |
Media type term |
computer |
Media type code |
c |
Source |
rdamedia |
338 ## - CARRIER TYPE |
Carrier type term |
online resource |
Carrier type code |
cr |
Source |
rdacarrier |
347 ## - DIGITAL FILE CHARACTERISTICS |
File type |
text file |
Encoding format |
PDF |
Source |
rda |
505 0# - FORMATTED CONTENTS NOTE |
Formatted contents note |
Preface -- Foreword -- 1. Hypotheses, Data, Stratification -- 2. The analysis of efficacy data of drug trials -- 3. The analysis of safety data of drug trials -- 4. Equivalence testing -- 5. Statistical power and sample size -- 6. Interim analysis -- 7. Multiple statistical inferences -- 8. Principles of linear regression -- 9. Subgroup analysis multiple linear regression: confounding, interaction, synergism -- 10. Curvilinear regression -- 11. Meta-analysis -- 12. Crossover studies with continuous variables: power analysis -- 13. Crossover studies with binary responses -- 14. Post-hoc analysis in clinical trials, a case for logistic regression analysis -- 15. quality-of-life assessment in clinical trials -- 16. Statistics for the analysis of genetic data -- 17. Relationship among statistical distributions -- 18. Statistics is not "bloodless" algebra -- Appendix -- Index. |
520 ## - SUMMARY, ETC. |
Summary, etc. |
In 1948 the first randomized controlled trial was published by the English Medical Research Council in the British Medical Journal. Until then, observations had been uncontrolled. Initially, trials frequently did not confirm hypotheses to be tested. This phenomenon was attributed to low sensitivity due to small samples, as well as inappropriate hypotheses based on biased prior trials. Additional flaws were recognized and subsequently were better accounted for: carryover effects due to insufficient washout from previous treatments, time effects due to external factors and the natural history of the condition under study, bias due to asymmetry between treatment groups, lack of sensitivity due to a negative correlation between treatment responses, etc. Such flaws, mainly of a technical nature, have been largely corrected and led to trials after 1970 being of significantly better quality than before. The past decade has focused, in addition to technical aspects, on the need for circumspection in planning and conducting of clinical trials. As a consequence, prior to approval, clinical trial protocols are now routinely scrutinized by different circumstantial bodies, including ethics committees, institutional and federal review boards, national and international scientific organizations, and monitoring committees charged with conducting interim analyses. This book not only explains classical statistical analyses of clinical trials, but addresses relatively novel issues, including equivalence testing, interim analyses, sequential analyses, and meta-analyses, and provides a framework of the best statistical methods currently available for such purposes. The book is not only useful for investigators involved in the field of clinical trials, but also for all physicians who wish to better understand the data of trials as currently published. |
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name entry element |
Statistics. |
650 14 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name entry element |
Statistics. |
650 24 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name entry element |
Statistics for Life Sciences, Medicine, Health Sciences. |
700 1# - ADDED ENTRY--PERSONAL NAME |
Personal name |
Zwinderman, Aeilko H. |
Relator term |
author. |
700 1# - ADDED ENTRY--PERSONAL NAME |
Personal name |
Cleophas, Toine F. |
Relator term |
author. |
710 2# - ADDED ENTRY--CORPORATE NAME |
Corporate name or jurisdiction name as entry element |
SpringerLink (Online service) |
773 0# - HOST ITEM ENTRY |
Title |
Springer eBooks |
776 08 - ADDITIONAL PHYSICAL FORM ENTRY |
Relationship information |
Printed edition: |
International Standard Book Number |
9781402042294 |
856 40 - ELECTRONIC LOCATION AND ACCESS |
Uniform Resource Identifier |
http://dx.doi.org/10.1007/1-4020-0570-9 |
912 ## - |
-- |
ZDB-2-SMA |